Dispersion Durations of P-wave and QT Interval in Children With Congenital Heart Disease and Pulmonary Arterial Hypertension

Basit Öğe Kaydı
dc.contributor.authorSap, Fatih
dc.contributor.authorKaratas, Zehra
dc.contributor.authorAltin, Hakan
dc.contributor.authorAlp, Hayrullah
dc.contributor.authorOran, Bulent
dc.contributor.authorBaysal, Tamer
dc.contributor.authorKaraarslan, Sevim
dc.date.accessioned2024-02-23T13:43:34Z
dc.date.available2024-02-23T13:43:34Z
dc.date.issued2013
dc.departmentNEÜen_US
dc.description.abstractThis study aimed to investigate homogeneity disorders of ventricular repolarization and atrial conduction via QT dispersion and P-wave dispersion in children with congenital heart disease (CHD) and pulmonary arterial hypertension (PAH). Three groups of 20 each were generated and involved in this study. The first group included 20 children with both CHD and PAH. The second group consisted of 20 children with CHD but no PAH, and the third group was composed of 20 age- and sex-matched healthy children. Electrocardiographic records were used to determine P-wave, QT, and corrected QT (QTc) dispersions. The pulmonary hypertension group compared with the group having no pulmonary hypertension and the control group showed a significantly longer P-wave dispersion duration (39.10 +/- A 9.54 vs. 26.30 +/- A 4.99 ms, p < 0.001; and 24.80 +/- A 6.94 ms, p < 0.001, respectively) and QT dispersion duration (52.80 +/- A 15.11 vs. 37.60 +/- A 6.00 ms, p < 0.001; and 35.00 +/- A 7.77 ms, p < 0.001, respectively). In addition, the durations of maximum QTc and QTc dispersion were significantly longer in pulmonary hypertension group than in the other two groups. The risk of atrial and ventricular arrhythmia was found to be increased in the patients with both CHD and PAH. Physicians should pay close attention to possible atrial and ventricular arrhythmias during the treatment and follow-up evaluation of these patients.en_US
dc.identifier.doi10.1007/s00246-012-0503-5
dc.identifier.endpage596en_US
dc.identifier.issn0172-0643
dc.identifier.issn1432-1971
dc.identifier.issue3en_US
dc.identifier.pmid22972516en_US
dc.identifier.scopus2-s2.0-84879505967en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage591en_US
dc.identifier.urihttps://doi.org/10.1007/s00246-012-0503-5
dc.identifier.urihttps://hdl.handle.net/20.500.12452/10859
dc.identifier.volume34en_US
dc.identifier.wosWOS:000315567200017en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofPediatric Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiac Defectsen_US
dc.subjectChildhooden_US
dc.subjectElectrocardiographic Markersen_US
dc.subjectPressure Of Pulmonary Vasculatureen_US
dc.titleDispersion Durations of P-wave and QT Interval in Children With Congenital Heart Disease and Pulmonary Arterial Hypertensionen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu